Phentermine And Topiramate
Obesity Treatment With Phentermine-Topiramate ER in AYA Surviving Leukemia and Lymphoma
VIVUS · Phase 2 · Not yet recruiting · Enrollment 100
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
No selected arm reports a responder percent.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| phentermine topiramate extended release (PHEN/TOP) + Health Behavior and Lifestyle Counseling | n/r | n/r | n/r | n/r |
| Health Behavior and Lifestyle Counseling Alone (SOC [Standard of Care]) | n/r | n/r | n/r | n/r |
Not shown
- phentermine topiramate extended release (PHEN/TOP) + Health Behavior and Lifestyle Counseling: endpoint not reported
- Health Behavior and Lifestyle Counseling Alone (SOC [Standard of Care]): endpoint not reported